Back

Lp(a) as independent causal risk factor: why should we focus on testing?

28 August 2022 (10:25 - 10:40)
Organised by:
Congress Presentation Part of: Lp(a): from causality to therapy Lipid-Lowering Agents Open Access ESC Congress 2022

About the speaker

Photo
Professor Florian Kronenberg

Medical University of Innsbruck, Innsbruck (Austria)

3 More presentations in this session

Presentation thumbnail
Targeting Lp(a) in CV risk reduction: where are we now?
Professor P. Kamstrup (Copenhagen, DK)
Slides Video
Presentation thumbnail
Targeting Lp(a): therapeutic insights and novel developments.
Professor E. Stroes (Amsterdam, NL)
Slides Video
Presentation thumbnail
Discussion.
Professor E. Stroes (Amsterdam, NL) Professor P. Kamstrup (Copenhagen, DK) Professor F. Kronenberg (Innsbruck, AT)
Slides Video

Access the full session

Session thumbnail
Lp(a): from causality to therapy
Video

The Event

Event poster

ESC Congress 2022

28 August 2022 10:25 CET
You may be interested in
thumbnail
Congress Presentation
Lp(a) testing is simple
31 August 2024
thumbnail
Congress Session
Young Investigator Awards Session in Population Sciences
25 August 2023
thumbnail
Congress Presentation
Protein biomarkers in cardiovascular disease.
29 August 2022
thumbnail
Congress Presentation
Intraindividual variability in lipoprotein(a): the value of a repeat measure for reclassifying individuals at intermediate-risk
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources